Bupropion for ADHD in Adolescents with Substance Use Disorders

安非他酮治疗患有药物使用障碍的青少年多动症

基本信息

项目摘要

DESCRIPTION (provided by applicant): This application is a revised resubmission of R01 DA022284, initially reviewed by NIDA-L in June 2006. The application proposes a randomized, placebo-controlled trial of bupropion + cognitive behavioral therapy (CBT) to evaluate the efficacy of this combined therapy for attention deficit hyperactivity disorder (ADHD) in adolescents in whom these disorders commonly co-occur. ADHD is one of the most common co-occurring psychiatric disorders (30-50%) in adolescents with substance use disorders (SUD) and has been associated with more severe drug abuse, school failure, long-term psychosocial impairment, and poorer substance treatment outcomes. Research has shown that bupropion is a safe and effective treatment for both ADHD and nicotine dependence in individuals without SUD, and newer research provides empirical support for its unique pharmacotherapeutic properties and potential for treating other addictive disorders (e.g., methamphetamine dependence, pathological gambling). No controlled studies have yet evaluated bupropion's safety and efficacy for ADHD and SUD (including nicotine and cannabis) in adolescents. The lack of research on the safety and efficacy of medications in adolescents with SUD and psychiatric comorbidities contributes to a serious lack of integrated treatment for commonly co-occurring mental health and substance problems in community-based adolescent drug treatment programs. This then contributes to poorer treatment outcomes and prognosis for the large number of comorbid youths with substance abuse and mental health problems that significantly impact public health. The specific aims of the proposed study will address this research gap by conducting a 16-week randomized controlled trial of bupropion vs. placebo to evaluate the safety and efficacy of this low abuse potential medication on ADHD, nicotine dependence, and cannabis use disorders (not excluding other SUD) in 130 adolescents (13-19) receiving concurrent outpatient substance treatment (CBT). The study design and analytic approach will enable assessment of the complex inter-relationship between change in ADHD, depression/dysphoria (and other psychiatric symptoms) and change in nicotine, cannabis and other substance use within and between treatment groups. Thus, the application addresses important research gaps in at least two priority areas of the NIDA/NIH research agenda: 1) research on effective treatments for adolescents with addiction and psychiatric comorbidity, and 2) medications development research for nicotine and cannabis use disorders in adolescents.
描述(申请人提供):本申请是由NIDA-L于2006年6月首次审查的R01DA022284的修订后的重新提交。该申请提出了一项安慰剂对照的随机试验,即安非他酮+认知行为疗法(CBT),以评估这种联合疗法对青少年注意缺陷多动障碍(ADHD)的疗效,这些疾病通常是这些疾病共同发生的。ADHD是患有物质使用障碍(SUD)的青少年中最常见的共生精神障碍之一(30%-50%),并与更严重的药物滥用、学业失败、长期心理社会障碍和较差的药物治疗结果有关。研究表明,安非他酮是一种安全有效的治疗ADHD和尼古丁依赖的药物,新的研究为其独特的药物治疗特性和治疗其他成瘾疾病(如甲基苯丙胺依赖、病理性赌博)的潜力提供了经验支持。目前还没有对照研究评估安非他酮治疗青少年ADHD和SUD(包括尼古丁和大麻)的安全性和有效性。缺乏对患有SUD和精神疾病共病的青少年用药的安全性和有效性的研究,导致社区青少年药物治疗计划中严重缺乏对常见的共生心理健康和物质问题的综合治疗。这导致大量患有严重影响公共健康的药物滥用和精神健康问题的青少年的治疗结果和预后较差。这项拟议研究的具体目标将通过进行为期16周的安非他酮与安慰剂的随机对照试验来填补这一研究空白,以评估这种低滥用潜力药物在130名同时接受门诊药物治疗(CBT)的青少年(13-19岁)中治疗ADHD、尼古丁依赖和大麻使用障碍(不包括其他SUD)的安全性和有效性。研究设计和分析方法将能够评估治疗组内和治疗组之间ADHD、抑郁/焦虑症(和其他精神症状)的变化与尼古丁、大麻和其他物质使用的变化之间的复杂相互关系。因此,该申请填补了NIDA/NIH研究议程至少两个优先领域的重要研究空白:1)对患有成瘾和精神疾病的青少年进行有效治疗的研究,以及2)针对青少年尼古丁和大麻使用障碍的药物开发研究。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Treatment of Adolescent Substance Use Disorders.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paula DeGraffenreid Riggs其他文献

Paula DeGraffenreid Riggs的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paula DeGraffenreid Riggs', 18)}}的其他基金

Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    8322985
  • 财政年份:
    2008
  • 资助金额:
    $ 58.56万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7840535
  • 财政年份:
    2008
  • 资助金额:
    $ 58.56万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7367685
  • 财政年份:
    2008
  • 资助金额:
    $ 58.56万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    8077427
  • 财政年份:
    2008
  • 资助金额:
    $ 58.56万
  • 项目类别:
Bupropion for ADHD in Adolescents with Substance Use Disorders
安非他酮治疗患有药物使用障碍的青少年多动症
  • 批准号:
    7675467
  • 财政年份:
    2008
  • 资助金额:
    $ 58.56万
  • 项目类别:
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION
物质依赖青少年——治疗抑郁症的影响
  • 批准号:
    6653679
  • 财政年份:
    2000
  • 资助金额:
    $ 58.56万
  • 项目类别:
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE
落基山区域临床试验节点
  • 批准号:
    7029121
  • 财政年份:
    2000
  • 资助金额:
    $ 58.56万
  • 项目类别:
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE
落基山区域临床试验节点
  • 批准号:
    6889322
  • 财政年份:
    2000
  • 资助金额:
    $ 58.56万
  • 项目类别:
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION
物质依赖青少年——治疗抑郁症的影响
  • 批准号:
    6646416
  • 财政年份:
    2000
  • 资助金额:
    $ 58.56万
  • 项目类别:
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE
落基山区域临床试验节点
  • 批准号:
    6798709
  • 财政年份:
    2000
  • 资助金额:
    $ 58.56万
  • 项目类别:

相似海外基金

Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
  • 批准号:
    10608426
  • 财政年份:
    2023
  • 资助金额:
    $ 58.56万
  • 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
  • 批准号:
    486580
  • 财政年份:
    2022
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
  • 批准号:
    MR/V032380/1
  • 财政年份:
    2022
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/1
  • 财政年份:
    2021
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
  • 批准号:
    455984
  • 财政年份:
    2021
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/2
  • 财政年份:
    2021
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
  • 批准号:
    10057761
  • 财政年份:
    2020
  • 资助金额:
    $ 58.56万
  • 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
  • 批准号:
    10213683
  • 财政年份:
    2020
  • 资助金额:
    $ 58.56万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 58.56万
  • 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
  • 批准号:
    356145
  • 财政年份:
    2016
  • 资助金额:
    $ 58.56万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了